6533b7d5fe1ef96bd126532b

RESEARCH PRODUCT

Structural Approaches to Explain the Selectivity of COX-2 Inhibitors: Is There a Common Pharmacophore?

Gerd DannhardtStefan Laufer

subject

Polarity (physics)StereochemistryComputational biologyBiochemistryPyrrole derivativesStructure-Activity RelationshipProstaglandin-Endoperoxide SynthaseDrug DiscoverymedicineAnimalsHumansCyclooxygenase InhibitorsPharmacologyCyclooxygenase 2 InhibitorsMolecular StructureChemistryAnti-Inflammatory Agents Non-SteroidalOrganic ChemistryMembrane ProteinsRecombinant ProteinsIsoenzymesMechanism of actionCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesBenzene derivativesLipophilicityMolecular Medicinemedicine.symptomPharmacophoreSelectivity

description

The identification and characterisation of the isoenzyme cyclooxygenase 2 (COX-2) stimulated investigations to develop efficient non-steroidal anti-inflammatory drugs with reduced side effects compared to standard NSAIDs. This review will focus on the structural features needed to achieve COX-2 selectivity. Five structural classes can be identified together with a class bearing little or no resemblance to one another in their molecular structure. The most interesting point is the very distinct structure/activity relationship. On the one hand only minor modifications to a particular compound induce a drastic change in its COX selectivity and on the other hand the structural prerequisites in terms of molecular shape, lipophilicity, electron density, flexibility, polarity and H-bonding dynamics allow a wide range of diversity.

https://doi.org/10.2174/0929867003374237